Results 181 to 190 of about 37,693 (353)

Retrospective analysis of the diagnostic spectrum of histological nephropathies from the Magdeburg kidney biopsy cohort (MD-KBC). [PDF]

BMC Nephrol
Mertens PR, Kanaan MR, Abou-Watfa AA, Bender ST, Wiech T, Gröne HJ, Scurt FG.   +6 more
europepmc   +1 more source

Insulin therapy DE‐intensificAtion with iGlarLixi: A phase 4, open‐label, parallel‐group randomised controlled trial

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To evaluate the efficacy and safety of transitioning from multiple daily injections (MDIs) insulin regimen to once‐daily, fixed‐ratio combination of basal insulin analog glargine 100 U/mL and a glucagon‐like peptide 1 receptor agonist lixisenatide (iGlarLixi) in people with type 2 diabetes (PwT2D). Materials and Methods Insulin therapy DE‐
Peter Novodvorský, Lenka Thieme, Ivana Laňková, Štěpánka Franková, Alica Veselá, Emil Záhumenský, Tomáš Edelsberger, Marie Löblová, Ondřej Žižka, Miroslav Vytasil, Felipe Lauand, Mireille Bonnemaire, Filip Hrubý, Miloš Mráz, Martin Haluzík   +14 more
wiley   +1 more source

Studies of Diabetic Nephropathy. I. Effects of Storage Time and Temperature on Microalbuminuria.

, 1994
Fumiko Hara, Kyomi Nakazato, Kiyoko Shiba, Junko Shimoda, Tomie KOJIMA, Y Fukumura, Isao Kobayashi   +6 more
openalex   +2 more sources

Alterations of glomerular basement membrane charge and structure in diabetic nephropathy [PDF]

, 1995
N. P. Goode, Mike Shires, D. Crellin, S. R. Aparicio, A. M. Davison   +4 more
openalex   +1 more source

Efficacy and safety of finerenone combined with sodium-glucose cotransporter 2 inhibitors in diabetic kidney disease: protocol for a systematic review and meta-analysis. [PDF]

BMJ Open
Wang X, Yu Y, Xiang Y, Liu X, Yu R.
europepmc   +1 more source

CGM‐derived average glucose is more strongly associated with microvascular complications than HbA1c in type 1 diabetes

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To compare the associations of HbA1c and continuous glucose monitoring (CGM)‐derived average glucose with microvascular complications in adults with type 1 diabetes, and to assess the clinical utility and stability of metrics capturing glycation discordance. Materials and methods Observational assessment of 9023 paired measurements of CGM
Roland H. Stimson, Michael S. Crane, Anna R. Dover, Shareen Forbes, Rohana J. Wright, Marcus J. Lyall, Mark W. J. Strachan, Fraser W. Gibb   +7 more
wiley   +1 more source

Peritoneal dialysis as a treatment option in autosomal dominant polycystic kidney disease [PDF]

, 2015
Bolesław Rutkowski, Magdalena Jankowska, Michał Chmielewski, Monika Lichodziejewska-Niemierko, Piotr Jagodziński   +4 more
core   +1 more source

Interleukin-10 gene promoter variants and susceptibility to diabetic nephropathy; a meta-analysis [PDF]

, 2020
Gita Mishra, Sudeep Gautam, Thavanati Parvathi Kumara Reddy, L.V.K.S. Bhaskar   +3 more
openalex   +1 more source

A non-invasive urinary diagnostic signature for diabetic kidney disease revealed by machine learning and single-cell analysis. [PDF]

PLoS One
Chen Y, Luo J, Zheng Y, Jiang X, Yang Z, Liu X.   +5 more
europepmc   +1 more source

Association between glucagon‐like peptide‐1 receptor agonists and risk of dementia in older adults with type 2 diabetes: A target trial emulation

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aim Type 2 diabetes (T2D) is associated with increased dementia risk, but comparative data across newer glucose‐lowering therapies remain limited. We examined whether the initiation of GLP‐1 receptor agonists (GLP‐1 RAs) was associated with incident dementia compared with DPP4 inhibitors (DPP4is) and SGLT2 inhibitors (SGLT2is) in older adults ...
Ting Zhou, Huilin Tang, Bingyu Zhang, Dazheng Zhang, Yiwen Lu, Lu Li, Jiajie Chen, Yong Chen, David A. Asch, Yong Chen   +9 more
wiley   +1 more source